Galapagos And Blood Centers Of America Collaborate To Expand Galapagos' Decentralized CAR-T Manufacturing Network In The U.S.
Portfolio Pulse from Benzinga Newsdesk
Galapagos NV (NASDAQ: GLPG) has entered into a strategic collaboration with Blood Centers of America (BCA) to expand its decentralized CAR-T manufacturing network in the U.S. This partnership will leverage BCA's extensive network of blood centers to enhance the manufacturing and distribution of Galapagos' CAR-T therapies, improving patient access and supporting upcoming pivotal trials.
May 15, 2024 | 8:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Galapagos NV has partnered with Blood Centers of America to expand its decentralized CAR-T manufacturing network in the U.S. This collaboration is expected to improve patient access to CAR-T therapies and support upcoming pivotal trials, marking a significant milestone in Galapagos' U.S. expansion strategy.
The partnership with BCA will enable Galapagos to leverage a vast network of blood centers for decentralized manufacturing, which is crucial for the rapid deployment and scalability of its CAR-T therapies. This is likely to enhance patient access and support pivotal trials, positively impacting the company's growth and stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100